BioStorage Technologies and Crohn’s & Colitis Foundation Collaborate to Advance IBD Plexus Initiative for Precision Medicine

BioStorage Technologies and Crohn’s & Colitis Foundation Collaborate to Advance IBD Plexus Initiative for Precision Medicine
BioStorage Technologies, a worldwide leader in comprehensive sample management solutions, has entered into a strategic collaboration with the Crohn's & Colitis Foundation of America (CCFA) to provide transformative technology services and pioneering sample management solutions across the full sample lifecycle comprising logistics, kitting, bioprocessing, storage and supply of samples for its novel IBD Plexus initiative. At the beginning of 2015, the CCFA was granted an award from The Leona M. and Harry B. Helmsley Charitable Trust to develop a platform of integrated knowledge with the aim of centralizing and aggregating patient data – with accompanying biosamples – across multiple research studies efforts. The innovative initiative, termed IBD Plexus, was developed to speed advancement toward precision medicine through novel research studies, with the aim of leading to better diagnostics, treatments, and eventually cures for inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. The new platform will allow clinicians, industry, and academic researchers as well as other healthcare professionals to investigate IBD in patients of all ages. The resource will nurture partnerships among stakeholders and is driven by a shared objective of supporting better clinical care, improving treatments, and ultimately finding a cure for the diseases. The IBD Plexus project includes a biobank, registries to capture patients clinical information, patient-reported data, biosample data (including genetic, genomic, microbiomic, among others), and a large platform for managing data, with the aim of
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *